Maryland Man Sues Novo Nordisk Over Ozempic, Claiming 2 Eye Strokes Left Him Blind
Updated
Updated · Fox News · Oct 14
Maryland Man Sues Novo Nordisk Over Ozempic, Claiming 2 Eye Strokes Left Him Blind
3 articles · Updated · Fox News · Oct 14
Summary
Todd Engel, 63, alleges in a lawsuit that Ozempic caused NAION in both eyes, leaving him legally blind after he began taking the diabetes drug in 2023.
About 4 months after starting Ozempic, Engel says he lost vision in his right eye and was diagnosed with an "eye stroke"; roughly 10 months later, he says the same condition struck his left eye.
The suit claims Novo Nordisk failed to warn patients and doctors about a potential vision-loss risk, and Engel's lawyer says the case seeks a U.S. label warning similar to information provided in Europe.
Novo Nordisk disputes any causal link, saying clinical-trial data showed very few confirmed NAION cases and no increased incidence among semaglutide users, and calls the U.S. injury suits meritless.
Engel is among hundreds of patients pursuing GLP-1 lawsuits over NAION, a link that has not been definitively established but could widen scrutiny of Ozempic and related drugs.